Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Algal oil is primarily valued for its high content of omega-3 fatty acids, particularly docosahexaenoic acid (DHA) and, to a lesser extent, eicosapentaenoic acid (EPA). The rationale for using algal oil in Inflammatory Bowel Disorders (IBD), such as Crohn's disease and ulcerative colitis, stems from evidence that omega-3 fatty acids can modulate inflammatory responses. Several preclinical studies and a few small clinical trials have investigated the effects of omega-3 supplementation on IBD outcomes, with mixed but somewhat promising results in terms of reducing disease activity and maintaining remission. Algal oil offers a plant-based, sustainable alternative to fish oil, with similar bioactive omega-3 content but without the risk of marine contaminants. However, the overall level of scientific evidence supporting algal oil specifically (rather than generic omega-3s or fish oil) in IBD is limited: most clinical studies have used fish-derived omega-3s, and algal oil itself has not been extensively tested in large, high-quality trials for IBD. Thus, while mechanistic reasoning and indirect evidence provide a scientific basis for its use, direct evidence is currently weak and further research is needed to establish its efficacy for IBD management.

More about algal oil
More about Inflammatory Bowel Disorders

Other ingredients used for Inflammatory Bowel Disorders

Other health conditions supported by algal oil

Products containing algal oil

Metagenics OmegaGenics Algae EPA-DHA 300 mg